MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0056912
Knovea Pharmaceutical Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹62.7 Lakh
▲ 321% YoY
Net loss · FY 2025
₹13.81 Cr
Latest filing
EBITDA · FY 2025
-₹9.98 Cr
Latest filing
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹157.22 Cr
Satisfied ₹51.5 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
115
Provident fund records
About Knovea Pharmaceutical Private Limited
Data last updated:
Knovea Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India, a subsidiary of Symbiotec Pharmalab Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24110MP2020PTC050978. Its GSTIN is 23AAICK0245N1ZI (Madhya Pradesh).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Anil Satwani and Rohit Brijmohan Mantri.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh. No.385/2 Vill. Pigdamber Rau, Indore, Madhya Pradesh, India – 453331.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.7 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13.81 Cr and EBITDA of -₹9.98 Cr. Revenue has declined at a compounded annual rate (CAGR) of 77% over three years.
The company has about 115 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Knovea and Symbiotec. As per MCA filings, the company has open charges of ₹157.22 Cr and satisfied charges of ₹51.5 Cr on record.
Knovea Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0056912). For more details, the company can be reached via its website knovea.com.
Company details
CIN U24110MP2020PTC050978
Registration Number 050978
Incorporation Date 17 February 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Symbiotec Pharmalab Private Limited
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0056912
Key People
Anil Satwani Director Rohit Brijmohan Mantri Nominee Director Buggana Hariharnath Nominee Director Recognitions & Rankings of Knovea Pharmaceutical
Contact details
Knovea Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh. Its website is knovea.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressKh. No.385/2 Vill. Pigdamber Rau, Indore, Madhya Pradesh, India – 453331
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Knovea Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Knovea Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Knovea Pharmaceutical operates two associated brands: Knovea and Symbiotec. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Non-sterile steroid hormone-based APIs and intermediates are manufactured. | symbiotec.in | |
| Pharmaceutical manufacturing, R&D, and quality services in India. | knovea.com |
Business activity
The main business activities of Knovea Pharmaceutical are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Knovea Pharmaceutical Private Limited, buy the company report.
Financials of Knovea Pharmaceutical Private Limited
FY 2025 filings availableKnovea Pharmaceutical Private Limited reported revenue of ₹62.7 Lakh (up 321% YoY) for FY 2025.
Revenue · FY 2025
₹62.7 Lakh ▲ 321%
Net loss · FY 2025
₹13.81 Cr
EBITDA · FY 2025
-₹9.98 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 321%
3 years · compounded
▼ 77%
EBITDA CAGR growth
1 year
▼ 29%
3 years · compounded
▼ 31%
Revenue rose 321% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 77%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.81 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Knovea Pharmaceutical Private Limited, buy the company report.
Board of directors of Knovea Pharmaceutical Private Limited
Knovea Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Satwani | Director | 17 Feb 2020 | 6 Years 8 Months | Current |
| Rohit Brijmohan Mantri Also directs: Symbiotec Biologics Private Limited, Symbiotec Zenfold Private Limited, Symbiotec Pharmalab Limited and 5 more | Nominee Director | 17 Feb 2020 | 6 Years 8 Months | Current |
| Buggana Hariharnath Also directs: Symbiotec Zenfold Private Limited, Invascent Advisory Services India LLP, Invascent Ilsf Manager LLP and 4 more | Nominee Director | 16 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Knovea Pharmaceutical Private Limited is audited by S R B C & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & Co. LLP | FY 2023 | 324982E/E300003 |
Shareholding
The shareholding of Knovea Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Knovea Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹157.22 Cr
Satisfied charges
₹51.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2022 | 100603810 | Sbicap Trustee Company Limited | ₹157.22 Cr | Open | |
| 26 Sep 2024 | 100984304 | Axis Bank Limited | ₹18 Cr | Satisfied | |
| 23 Sep 2021 | 100488054 | Axis Bank Limited | ₹33.5 Cr | Satisfied |
To see the full charge records of Knovea Pharmaceutical Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Knovea Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Knovea Pharmaceutical Private Limited was last rated by Care on 12 Dec 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 12 Dec 2022 |
To see the full credit ratings and regulatory alerts of Knovea Pharmaceutical Private Limited, buy the company report.
MSME payment delays
Knovea Pharmaceutical Private Limited has 10 MSME Form 1 returns on record between 2021 and 2024, listing 104 overdue payments to 29 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 29)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Neon Corporation | |||
| Pragati Graphics and Packaging Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Mamleshwar Green Fuel Private Limited |
To see the full MSME payment records of Knovea Pharmaceutical Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Knovea Pharmaceutical Private Limited has a workforce of 115 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
115
Active EPFO establishments
1
Employee growth
139.58%
GST
Knovea Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICK0245N1ZI | Madhya Pradesh | Active | 17 Mar 2020 |
To see the full GST registrations and return filing status of Knovea Pharmaceutical Private Limited, buy the company report.
Recent activity
Knovea Pharmaceutical Private Limited has 5 board changes on record since 2020: 4 appointments and 1 cessation. The latest: Buggana Hariharnath was appointed as Nominee Director on 16 Sep 2024.
AGM
Knovea Pharmaceutical Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Charges
A charge registered on 26 Sep 2024 via Charge ID 100984304 with Axis Bank Limited was fully satisfied on 26 Jun 2025.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 157.22 Cr registered on 01 Sep 2022 with Charge ID 100603810 was modified on 08 May 2025.
Filing
Knovea Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Axis Bank Limited amounted to Rs. 18.00 Cr with Charge ID 100984304 was registered on 26 Sep 2024.
Appointed
Buggana Hariharnath was appointed as Nominee Director.
Ceased
Sumit Gupta ceased to be Nominee Director.
Charges
A charge registered on 23 Sep 2021 via Charge ID 100488054 with Axis Bank Limited was fully satisfied on 06 Mar 2023.
Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 157.22 Cr with Charge ID 100603810 was registered on 01 Sep 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 33.50 Cr with Charge ID 100488054 was registered on 23 Sep 2021.
Appointed
Anil Satwani was appointed as Director.
Appointed
Rohit Brijmohan Mantri was appointed as Nominee Director.
2 earlier events are in the company report.
Frequently asked questions
Knovea Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2020 (6+ years old) and is registered under CIN U24110MP2020PTC050978.
Knovea Pharmaceutical has 3 current directors:
- Anil Satwani - Director
- Rohit Brijmohan Mantri - Nominee Director
- Buggana Hariharnath - Nominee Director
The latest financial statements of Knovea Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Knovea Pharmaceutical is 23AAICK0245N1ZI, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Knovea Pharmaceutical is U24110MP2020PTC050978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Knovea Pharmaceutical was incorporated on 17 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
Buggana Hariharnath was appointed as Nominee Director on 16 Sep 2024. Sumit Gupta ceased to be Nominee Director on 04 Sep 2024. Anil Satwani was appointed as Director on 17 Feb 2020. Knovea Pharmaceutical has 5 board changes on record in total.
Yes, Knovea Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0056912).
Knovea Pharmaceutical has 10 MSME Form 1 returns on record between 2021 and 2024, listing 104 overdue payments to 29 micro and small suppliers. The latest return was filed on 24 Apr 2024.
Knovea Pharmaceutical can be reached through the website knovea.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Knovea Pharmaceutical is at Kh. No.3852 Vill. Pigdamber Rau, Indore, Madhya Pradesh, India – 453331.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages